Defining a molecularly normal colon

Journal of Histochemistry and Cytochemistry

Volumn 49, Issue 5, 2001, Pages 667-668

  Murphy, Kelley J ^a   Nielson, Kandice R ^a   Albertine, Kurt H ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Colon cancer; Genomic mutations; Histology; Molecular pathology techniques

Indexed keywords

BETA CATENIN; CA 242 ANTIGEN; DNA TOPOISOMERASE (ATP HYDROLYSING); HEAT SHOCK PROTEIN 70; MUCIN; OCCLUDIN; PLAKOGLOBIN; UNCLASSIFIED DRUG; ZONULA OCCLUDINS 1;

ARTICLE; COLON ADENOCARCINOMA; COLON CANCER; COLON MUCOSA; COLON POLYP; CONTROLLED STUDY; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 0035026416     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540104900516     Document Type: Article

References (10)

1. Biemer-Huttmann A-E, Walsh MD, McGuckin MA, Ajioka Y, Watanabe H, Leggett BA, Jass JR (1999) Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and tradition adenomas of the colorectum. J Histochem Cytochem 47:1039-1047
2. Brabletz T, Herrmann K, Jung A, Faller G, Kirchner T (2000) Expression of nuclear β-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. AmJ Pathol 156:865-870
3. Gottardi CJ, Arpin M, Fanning AS, Louvard D (1996) The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc Natl Acad Sci USA 93:10779-10784
4. Hakimelahi S, Parker HR, Gilchrist AJ, Barry M, Li Z, Bleackley RC, Pasdar M (2000) Plakoglobin regulates the expression of the anti-apoptotic protein Bcl-2. J Biol Chem 275:10905-10911
5. Holden JA (1999) DNA topoisomerase II-alpha as a marker of cell proliferation in endocrine and other neoplasms. Endocrine Pathol 10:97-102
6. Jarvinen TAH, Tanner M, Rantanen V, Barlund M, Borg A, Grenman S, Isola J (2000) Amplification and deletion of topoisomerase IIα associate with ErfB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer. Am J Pathol 156:839-847
7. Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, Bodmer WF, Moyer MP, Riecken EO, Buhr HJ, Hanski C (1999) Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 96:1603-1608
8. Nylandsted J, Rohde M, Brand K, Bastholm L, Elling E, Jaattela M (2000) Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci USA 97:7871-7876
9. Quirke P, Mapstone N (1999) The new biology: histopathology. Lancet 354(suppl I):26-31
10. Stoler DL, Chen N, Basik M, Kahlenberg MS, Rodriguez-Bigas MA, Petrelli NJ, Anderson GR (1999) The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci USA 96:15121-15126